104 related articles for article (PubMed ID: 11377401)
1. Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
Carbone GM; Catapano CV; Fernandes DJ
Biochem Pharmacol; 2001 Jul; 62(1):101-10. PubMed ID: 11377401
[TBL] [Abstract][Full Text] [Related]
2. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
[TBL] [Abstract][Full Text] [Related]
3. A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-beta-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine.
Goz B; Bastow KF
Mutat Res; 1997 Aug; 384(2):89-106. PubMed ID: 9298118
[TBL] [Abstract][Full Text] [Related]
4. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
Grem JL; Geoffroy F; Politi PM; Cuddy DP; Ross DD; Nguyen D; Steinberg SM; Allegra CJ
Mol Pharmacol; 1995 Aug; 48(2):305-15. PubMed ID: 7651364
[TBL] [Abstract][Full Text] [Related]
5. Effect of cytarabine on the NMR structure of a model okazaki fragment from the SV40 genome.
Gmeiner WH; Konerding D; James TL
Biochemistry; 1999 Jan; 38(4):1166-75. PubMed ID: 9930976
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.
Preisler HD; Epstein J; Raza A; Azarnia N; Browman G; Booker L; Goldberg J; Gottlieb A; Brennan J; Grunwald H
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1061-8. PubMed ID: 6540689
[TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine in human plasma: potential for protecting leukemic cells during chemotherapy.
Cohen JD; Strock DJ; Teik JE; Katz TB; Marcel PD
Cancer Lett; 1997 Jun; 116(2):167-75. PubMed ID: 9215860
[TBL] [Abstract][Full Text] [Related]
8. The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.
Kaufman KL; Jenkins Y; Alomari M; Mirzaei M; Best OG; Pascovici D; Mactier S; Mulligan SP; Haynes PA; Christopherson RI
Oncotarget; 2015 Dec; 6(38):40981-97. PubMed ID: 26556860
[TBL] [Abstract][Full Text] [Related]
9. Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine.
Yoon JH; Roy Choudhury J; Prakash L; Prakash S
J Biol Chem; 2019 Dec; 294(50):19048-19054. PubMed ID: 31685662
[TBL] [Abstract][Full Text] [Related]
10. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
Li L; Keating MJ; Plunkett W; Yang LY
Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
[TBL] [Abstract][Full Text] [Related]
11. Comparative genotoxicity of 2,3'-O-cyclocytidine, beta-xylocytidine and 1-beta-D-arabinofuranosylcytosine in human tumor cell lines.
Mirzayans R; Cubitt S; Enns L; Karimian K; Radatus B; Hirani-Hojatti S; Murthy K; Paterson MC
Carcinogenesis; 1994 Oct; 15(10):2319-24. PubMed ID: 7525096
[TBL] [Abstract][Full Text] [Related]
12. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
13. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
Catapano CV; Chandler KB; Fernandes DJ
Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219
[TBL] [Abstract][Full Text] [Related]
16. Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines.
Sedlak J; Hunakova L; Duraj J; Chorvath B; Novotny L
Anticancer Drugs; 1995 Feb; 6(1):70-6. PubMed ID: 7756686
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
Raza A; Kuliczkowski K; Weidong G; Preisler HD
Med Oncol Tumor Pharmacother; 1984; 1(3):163-8. PubMed ID: 6544897
[TBL] [Abstract][Full Text] [Related]
18. Cytarabine-induced destabilization of a model Okazaki fragment.
Gmeiner WH; Skradis A; Pon RT; Liu J
Nucleic Acids Res; 1998 May; 26(10):2359-65. PubMed ID: 9580686
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine.
Rechkoblit O; Choudhury JR; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2018 Aug; 8(1):12702. PubMed ID: 30140014
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.
Tosi P; Visani G; Ottaviani E; Manfori S; Zinzani PL; Tura S
Leukemia; 1994 Dec; 8(12):2076-82. PubMed ID: 7528855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
